COVID-19 Impact on Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, Status and Forecast 2020-2026
This report focuses on the global HIV Integrase Strand Transfer Inhibitors (INSTI) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HIV Integrase Strand Transfer Inhibitors (INSTI) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Adcock Ingram Limited
- Affine Formulations Limited
- Aurobindo Pharma
- Biocon Limited
- Bristol-Myers Squibb
- Cipla
- Emcure Pharmaceuticals
- Flamingo Pharmaceuticals Limited
- Gilead Sciences
- Hetero Drugs
- IPCA Laboratories
- Janssen Pharmaceutica (Johnson & Johnson)
- LAURUS Labs
- Medisist Pharma
- Merck
- Mylan
- Ranbaxy Pharmaceuticals
- Shanghai Desano Pharmaceuticals
- ViiV Healthcare (GSK)
- Raltegravir
- Elvitegravir Combination Drugs
- Dolutegravir and Its Combination Drug
- Bictegravir Combination Drug
- Cabotegravir
- Other
- Hospital
- Clinic
- Drug Center
- Other
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global HIV Integrase Strand Transfer Inhibitors (INSTI) status, future forecast, growth opportunity, key market and key players.
- To present the HIV Integrase Strand Transfer Inhibitors (INSTI) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue
1.4 Market Analysis by Type
1.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Raltegravir
1.4.3 Elvitegravir Combination Drugs
1.4.4 Dolutegravir and Its Combination Drug
1.4.5 Bictegravir Combination Drug
1.4.6 Cabotegravir
1.4.7 Other
1.5 Market by Application
1.5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Drug Center
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Impact
1.6.1 How the Covid-19 is Affecting the HIV Integrase Strand Transfer Inhibitors (INSTI) Industry
1.6.1.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and HIV Integrase Strand Transfer Inhibitors (INSTI) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for HIV Integrase Strand Transfer Inhibitors (INSTI) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Perspective (2015-2026)
2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Growth Trends by Regions
2.2.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Share by Regions (2015-2020)
2.2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Strategy
2.3.6 Primary Interviews with Key HIV Integrase Strand Transfer Inhibitors (INSTI) Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Market Size
3.1.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue (2015-2020)
3.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Players (2015-2020)
3.1.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio
3.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2019
3.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Area Served
3.4 Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service
3.5 Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Type (2015-2020)
4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2021-2026)
5 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
5.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
6.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in North America (2019-2020)
6.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
6.4 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
7.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in Europe (2019-2020)
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
7.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
8 CHINA
8.1 China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
8.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in China (2019-2020)
8.3 China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
8.4 China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
9.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in Japan (2019-2020)
9.3 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
9.4 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
10.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
10.4 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
11 INDIA
11.1 India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
11.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in India (2019-2020)
11.3 India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
11.4 India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
12.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in Central & South America (2019-2020)
12.3 Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
12.4 Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Adcock Ingram Limited
13.1.1 Adcock Ingram Limited Company Details
13.1.2 Adcock Ingram Limited Business Overview and Its Total Revenue
13.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.1.4 Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020))
13.1.5 Adcock Ingram Limited Recent Development
13.2 Affine Formulations Limited
13.2.1 Affine Formulations Limited Company Details
13.2.2 Affine Formulations Limited Business Overview and Its Total Revenue
13.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.2.4 Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.2.5 Affine Formulations Limited Recent Development
13.3 Aurobindo Pharma
13.3.1 Aurobindo Pharma Company Details
13.3.2 Aurobindo Pharma Business Overview and Its Total Revenue
13.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.3.4 Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.3.5 Aurobindo Pharma Recent Development
13.4 Biocon Limited
13.4.1 Biocon Limited Company Details
13.4.2 Biocon Limited Business Overview and Its Total Revenue
13.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.4.4 Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.4.5 Biocon Limited Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.5.4 Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 Cipla
13.6.1 Cipla Company Details
13.6.2 Cipla Business Overview and Its Total Revenue
13.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.6.4 Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.6.5 Cipla Recent Development
13.7 Emcure Pharmaceuticals
13.7.1 Emcure Pharmaceuticals Company Details
13.7.2 Emcure Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.7.4 Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.7.5 Emcure Pharmaceuticals Recent Development
13.8 Flamingo Pharmaceuticals Limited
13.8.1 Flamingo Pharmaceuticals Limited Company Details
13.8.2 Flamingo Pharmaceuticals Limited Business Overview and Its Total Revenue
13.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.8.4 Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.8.5 Flamingo Pharmaceuticals Limited Recent Development
13.9 Gilead Sciences
13.9.1 Gilead Sciences Company Details
13.9.2 Gilead Sciences Business Overview and Its Total Revenue
13.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.9.4 Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.9.5 Gilead Sciences Recent Development
13.10 Hetero Drugs
13.10.1 Hetero Drugs Company Details
13.10.2 Hetero Drugs Business Overview and Its Total Revenue
13.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.10.4 Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.10.5 Hetero Drugs Recent Development
13.11 IPCA Laboratories
10.11.1 IPCA Laboratories Company Details
10.11.2 IPCA Laboratories Business Overview and Its Total Revenue
10.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.11.4 IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.11.5 IPCA Laboratories Recent Development
13.12 Janssen Pharmaceutica (Johnson & Johnson)
10.12.1 Janssen Pharmaceutica (Johnson & Johnson) Company Details
10.12.2 Janssen Pharmaceutica (Johnson & Johnson) Business Overview and Its Total Revenue
10.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.12.4 Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.12.5 Janssen Pharmaceutica (Johnson & Johnson) Recent Development
13.13 LAURUS Labs
10.13.1 LAURUS Labs Company Details
10.13.2 LAURUS Labs Business Overview and Its Total Revenue
10.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.13.4 LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.13.5 LAURUS Labs Recent Development
13.14 Medisist Pharma
10.14.1 Medisist Pharma Company Details
10.14.2 Medisist Pharma Business Overview and Its Total Revenue
10.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.14.4 Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.14.5 Medisist Pharma Recent Development
13.15 Merck
10.15.1 Merck Company Details
10.15.2 Merck Business Overview and Its Total Revenue
10.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.15.4 Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.15.5 Merck Recent Development
13.16 Mylan
10.16.1 Mylan Company Details
10.16.2 Mylan Business Overview and Its Total Revenue
10.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.16.4 Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.16.5 Mylan Recent Development
13.17 Ranbaxy Pharmaceuticals
10.17.1 Ranbaxy Pharmaceuticals Company Details
10.17.2 Ranbaxy Pharmaceuticals Business Overview and Its Total Revenue
10.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.17.4 Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.17.5 Ranbaxy Pharmaceuticals Recent Development
13.18 Shanghai Desano Pharmaceuticals
10.18.1 Shanghai Desano Pharmaceuticals Company Details
10.18.2 Shanghai Desano Pharmaceuticals Business Overview and Its Total Revenue
10.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.18.4 Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.18.5 Shanghai Desano Pharmaceuticals Recent Development
13.19 ViiV Healthcare (GSK)
10.19.1 ViiV Healthcare (GSK) Company Details
10.19.2 ViiV Healthcare (GSK) Business Overview and Its Total Revenue
10.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.19.4 ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.19.5 ViiV Healthcare (GSK) Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue
1.4 Market Analysis by Type
1.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Raltegravir
1.4.3 Elvitegravir Combination Drugs
1.4.4 Dolutegravir and Its Combination Drug
1.4.5 Bictegravir Combination Drug
1.4.6 Cabotegravir
1.4.7 Other
1.5 Market by Application
1.5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Drug Center
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Impact
1.6.1 How the Covid-19 is Affecting the HIV Integrase Strand Transfer Inhibitors (INSTI) Industry
1.6.1.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and HIV Integrase Strand Transfer Inhibitors (INSTI) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for HIV Integrase Strand Transfer Inhibitors (INSTI) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Perspective (2015-2026)
2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Growth Trends by Regions
2.2.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Share by Regions (2015-2020)
2.2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Strategy
2.3.6 Primary Interviews with Key HIV Integrase Strand Transfer Inhibitors (INSTI) Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Market Size
3.1.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue (2015-2020)
3.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Players (2015-2020)
3.1.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio
3.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2019
3.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Area Served
3.4 Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service
3.5 Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Type (2015-2020)
4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2021-2026)
5 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
5.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
6.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in North America (2019-2020)
6.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
6.4 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
7.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in Europe (2019-2020)
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
7.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
8 CHINA
8.1 China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
8.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in China (2019-2020)
8.3 China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
8.4 China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
9.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in Japan (2019-2020)
9.3 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
9.4 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
10.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
10.4 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
11 INDIA
11.1 India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
11.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in India (2019-2020)
11.3 India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
11.4 India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2015-2020)
12.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players in Central & South America (2019-2020)
12.3 Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020)
12.4 Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Adcock Ingram Limited
13.1.1 Adcock Ingram Limited Company Details
13.1.2 Adcock Ingram Limited Business Overview and Its Total Revenue
13.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.1.4 Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020))
13.1.5 Adcock Ingram Limited Recent Development
13.2 Affine Formulations Limited
13.2.1 Affine Formulations Limited Company Details
13.2.2 Affine Formulations Limited Business Overview and Its Total Revenue
13.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.2.4 Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.2.5 Affine Formulations Limited Recent Development
13.3 Aurobindo Pharma
13.3.1 Aurobindo Pharma Company Details
13.3.2 Aurobindo Pharma Business Overview and Its Total Revenue
13.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.3.4 Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.3.5 Aurobindo Pharma Recent Development
13.4 Biocon Limited
13.4.1 Biocon Limited Company Details
13.4.2 Biocon Limited Business Overview and Its Total Revenue
13.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.4.4 Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.4.5 Biocon Limited Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.5.4 Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 Cipla
13.6.1 Cipla Company Details
13.6.2 Cipla Business Overview and Its Total Revenue
13.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.6.4 Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.6.5 Cipla Recent Development
13.7 Emcure Pharmaceuticals
13.7.1 Emcure Pharmaceuticals Company Details
13.7.2 Emcure Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.7.4 Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.7.5 Emcure Pharmaceuticals Recent Development
13.8 Flamingo Pharmaceuticals Limited
13.8.1 Flamingo Pharmaceuticals Limited Company Details
13.8.2 Flamingo Pharmaceuticals Limited Business Overview and Its Total Revenue
13.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.8.4 Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.8.5 Flamingo Pharmaceuticals Limited Recent Development
13.9 Gilead Sciences
13.9.1 Gilead Sciences Company Details
13.9.2 Gilead Sciences Business Overview and Its Total Revenue
13.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.9.4 Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.9.5 Gilead Sciences Recent Development
13.10 Hetero Drugs
13.10.1 Hetero Drugs Company Details
13.10.2 Hetero Drugs Business Overview and Its Total Revenue
13.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
13.10.4 Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
13.10.5 Hetero Drugs Recent Development
13.11 IPCA Laboratories
10.11.1 IPCA Laboratories Company Details
10.11.2 IPCA Laboratories Business Overview and Its Total Revenue
10.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.11.4 IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.11.5 IPCA Laboratories Recent Development
13.12 Janssen Pharmaceutica (Johnson & Johnson)
10.12.1 Janssen Pharmaceutica (Johnson & Johnson) Company Details
10.12.2 Janssen Pharmaceutica (Johnson & Johnson) Business Overview and Its Total Revenue
10.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.12.4 Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.12.5 Janssen Pharmaceutica (Johnson & Johnson) Recent Development
13.13 LAURUS Labs
10.13.1 LAURUS Labs Company Details
10.13.2 LAURUS Labs Business Overview and Its Total Revenue
10.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.13.4 LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.13.5 LAURUS Labs Recent Development
13.14 Medisist Pharma
10.14.1 Medisist Pharma Company Details
10.14.2 Medisist Pharma Business Overview and Its Total Revenue
10.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.14.4 Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.14.5 Medisist Pharma Recent Development
13.15 Merck
10.15.1 Merck Company Details
10.15.2 Merck Business Overview and Its Total Revenue
10.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.15.4 Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.15.5 Merck Recent Development
13.16 Mylan
10.16.1 Mylan Company Details
10.16.2 Mylan Business Overview and Its Total Revenue
10.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.16.4 Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.16.5 Mylan Recent Development
13.17 Ranbaxy Pharmaceuticals
10.17.1 Ranbaxy Pharmaceuticals Company Details
10.17.2 Ranbaxy Pharmaceuticals Business Overview and Its Total Revenue
10.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.17.4 Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.17.5 Ranbaxy Pharmaceuticals Recent Development
13.18 Shanghai Desano Pharmaceuticals
10.18.1 Shanghai Desano Pharmaceuticals Company Details
10.18.2 Shanghai Desano Pharmaceuticals Business Overview and Its Total Revenue
10.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.18.4 Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.18.5 Shanghai Desano Pharmaceuticals Recent Development
13.19 ViiV Healthcare (GSK)
10.19.1 ViiV Healthcare (GSK) Company Details
10.19.2 ViiV Healthcare (GSK) Business Overview and Its Total Revenue
10.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
10.19.4 ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
10.19.5 ViiV Healthcare (GSK) Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Key Market Segments
Table 2. Key Players Covered: Ranking by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue
Table 3. Ranking of Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Raltegravir
Table 6. Key Players of Elvitegravir Combination Drugs
Table 7. Key Players of Dolutegravir and Its Combination Drug
Table 8. Key Players of Bictegravir Combination Drug
Table 9. Key Players of Cabotegravir
Table 10. Key Players of Other
Table 11. COVID-19 Impact Global Market: (Four HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for HIV Integrase Strand Transfer Inhibitors (INSTI) Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for HIV Integrase Strand Transfer Inhibitors (INSTI) Players to Combat Covid-19 Impact
Table 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2015-2020)
Table 20. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Strategy
Table 26. Main Points Interviewed from Key HIV Integrase Strand Transfer Inhibitors (INSTI) Players
Table 27. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Players (2015-2020) (Million US$)
Table 28. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players (2015-2020)
Table 29. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2019)
Table 30. Global HIV Integrase Strand Transfer Inhibitors (INSTI) by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service
Table 33. Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 36. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Type (2015-2020)
Table 37. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2021-2026)
Table 38. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Application (2015-2020)
Table 39. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 40. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Application (2021-2026)
Table 41. North America Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 42. North America Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 43. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 44. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 45. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 46. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 47. Europe Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 49. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 50. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 51. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 52. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 53. China Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 54. China Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 55. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 56. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 57. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 58. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 59. Japan Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 61. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 62. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 63. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 64. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 67. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 69. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 71. India Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 72. India Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 73. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 74. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 75. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 76. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 77. Central & South America Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 79. Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 81. Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 83. Adcock Ingram Limited Company Details
Table 84. Adcock Ingram Limited Business Overview
Table 85. Adcock Ingram Limited Product
Table 86. Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 87. Adcock Ingram Limited Recent Development
Table 88. Affine Formulations Limited Company Details
Table 89. Affine Formulations Limited Business Overview
Table 90. Affine Formulations Limited Product
Table 91. Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 92. Affine Formulations Limited Recent Development
Table 93. Aurobindo Pharma Company Details
Table 94. Aurobindo Pharma Business Overview
Table 95. Aurobindo Pharma Product
Table 96. Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 97. Aurobindo Pharma Recent Development
Table 98. Biocon Limited Company Details
Table 99. Biocon Limited Business Overview
Table 100. Biocon Limited Product
Table 101. Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 102. Biocon Limited Recent Development
Table 103. Bristol-Myers Squibb Company Details
Table 104. Bristol-Myers Squibb Business Overview
Table 105. Bristol-Myers Squibb Product
Table 106. Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 107. Bristol-Myers Squibb Recent Development
Table 108. Cipla Company Details
Table 109. Cipla Business Overview
Table 110. Cipla Product
Table 111. Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 112. Cipla Recent Development
Table 113. Emcure Pharmaceuticals Company Details
Table 114. Emcure Pharmaceuticals Business Overview
Table 115. Emcure Pharmaceuticals Product
Table 116. Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 117. Emcure Pharmaceuticals Recent Development
Table 118. Flamingo Pharmaceuticals Limited Business Overview
Table 119. Flamingo Pharmaceuticals Limited Product
Table 120. Flamingo Pharmaceuticals Limited Company Details
Table 121. Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 122. Flamingo Pharmaceuticals Limited Recent Development
Table 123. Gilead Sciences Company Details
Table 124. Gilead Sciences Business Overview
Table 125. Gilead Sciences Product
Table 126. Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 127. Gilead Sciences Recent Development
Table 128. Hetero Drugs Company Details
Table 129. Hetero Drugs Business Overview
Table 130. Hetero Drugs Product
Table 131. Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 132. Hetero Drugs Recent Development
Table 133. IPCA Laboratories Company Details
Table 134. IPCA Laboratories Business Overview
Table 135. IPCA Laboratories Product
Table 136. IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 137. IPCA Laboratories Recent Development
Table 138. Janssen Pharmaceutica (Johnson & Johnson) Company Details
Table 139. Janssen Pharmaceutica (Johnson & Johnson) Business Overview
Table 140. Janssen Pharmaceutica (Johnson & Johnson) Product
Table 141. Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 142. Janssen Pharmaceutica (Johnson & Johnson) Recent Development
Table 143. LAURUS Labs Company Details
Table 144. LAURUS Labs Business Overview
Table 145. LAURUS Labs Product
Table 146. LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 147. LAURUS Labs Recent Development
Table 148. Medisist Pharma Company Details
Table 149. Medisist Pharma Business Overview
Table 150. Medisist Pharma Product
Table 151. Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 152. Medisist Pharma Recent Development
Table 153. Merck Company Details
Table 154. Merck Business Overview
Table 155. Merck Product
Table 156. Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 157. Merck Recent Development
Table 158. Mylan Company Details
Table 159. Mylan Business Overview
Table 160. Mylan Product
Table 161. Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 162. Mylan Recent Development
Table 163. Ranbaxy Pharmaceuticals Company Details
Table 164. Ranbaxy Pharmaceuticals Business Overview
Table 165. Ranbaxy Pharmaceuticals Product
Table 166. Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 167. Ranbaxy Pharmaceuticals Recent Development
Table 168. Shanghai Desano Pharmaceuticals Company Details
Table 169. Shanghai Desano Pharmaceuticals Business Overview
Table 170. Shanghai Desano Pharmaceuticals Product
Table 171. Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 172. Shanghai Desano Pharmaceuticals Recent Development
Table 173. ViiV Healthcare (GSK) Company Details
Table 174. ViiV Healthcare (GSK) Business Overview
Table 175. ViiV Healthcare (GSK) Product
Table 176. ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 177. ViiV Healthcare (GSK) Recent Development
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Key Market Segments
Table 2. Key Players Covered: Ranking by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue
Table 3. Ranking of Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Raltegravir
Table 6. Key Players of Elvitegravir Combination Drugs
Table 7. Key Players of Dolutegravir and Its Combination Drug
Table 8. Key Players of Bictegravir Combination Drug
Table 9. Key Players of Cabotegravir
Table 10. Key Players of Other
Table 11. COVID-19 Impact Global Market: (Four HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for HIV Integrase Strand Transfer Inhibitors (INSTI) Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for HIV Integrase Strand Transfer Inhibitors (INSTI) Players to Combat Covid-19 Impact
Table 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2015-2020)
Table 20. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Strategy
Table 26. Main Points Interviewed from Key HIV Integrase Strand Transfer Inhibitors (INSTI) Players
Table 27. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Players (2015-2020) (Million US$)
Table 28. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players (2015-2020)
Table 29. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2019)
Table 30. Global HIV Integrase Strand Transfer Inhibitors (INSTI) by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service
Table 33. Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 36. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Type (2015-2020)
Table 37. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2021-2026)
Table 38. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Application (2015-2020)
Table 39. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 40. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Application (2021-2026)
Table 41. North America Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 42. North America Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 43. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 44. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 45. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 46. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 47. Europe Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 49. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 50. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 51. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 52. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 53. China Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 54. China Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 55. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 56. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 57. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 58. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 59. Japan Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 61. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 62. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 63. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 64. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 67. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 69. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 71. India Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 72. India Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 73. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 74. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 75. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 76. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 77. Central & South America Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share (2019-2020)
Table 79. Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2015-2020)
Table 81. Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2015-2020)
Table 83. Adcock Ingram Limited Company Details
Table 84. Adcock Ingram Limited Business Overview
Table 85. Adcock Ingram Limited Product
Table 86. Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 87. Adcock Ingram Limited Recent Development
Table 88. Affine Formulations Limited Company Details
Table 89. Affine Formulations Limited Business Overview
Table 90. Affine Formulations Limited Product
Table 91. Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 92. Affine Formulations Limited Recent Development
Table 93. Aurobindo Pharma Company Details
Table 94. Aurobindo Pharma Business Overview
Table 95. Aurobindo Pharma Product
Table 96. Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 97. Aurobindo Pharma Recent Development
Table 98. Biocon Limited Company Details
Table 99. Biocon Limited Business Overview
Table 100. Biocon Limited Product
Table 101. Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 102. Biocon Limited Recent Development
Table 103. Bristol-Myers Squibb Company Details
Table 104. Bristol-Myers Squibb Business Overview
Table 105. Bristol-Myers Squibb Product
Table 106. Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 107. Bristol-Myers Squibb Recent Development
Table 108. Cipla Company Details
Table 109. Cipla Business Overview
Table 110. Cipla Product
Table 111. Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 112. Cipla Recent Development
Table 113. Emcure Pharmaceuticals Company Details
Table 114. Emcure Pharmaceuticals Business Overview
Table 115. Emcure Pharmaceuticals Product
Table 116. Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 117. Emcure Pharmaceuticals Recent Development
Table 118. Flamingo Pharmaceuticals Limited Business Overview
Table 119. Flamingo Pharmaceuticals Limited Product
Table 120. Flamingo Pharmaceuticals Limited Company Details
Table 121. Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 122. Flamingo Pharmaceuticals Limited Recent Development
Table 123. Gilead Sciences Company Details
Table 124. Gilead Sciences Business Overview
Table 125. Gilead Sciences Product
Table 126. Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 127. Gilead Sciences Recent Development
Table 128. Hetero Drugs Company Details
Table 129. Hetero Drugs Business Overview
Table 130. Hetero Drugs Product
Table 131. Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 132. Hetero Drugs Recent Development
Table 133. IPCA Laboratories Company Details
Table 134. IPCA Laboratories Business Overview
Table 135. IPCA Laboratories Product
Table 136. IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 137. IPCA Laboratories Recent Development
Table 138. Janssen Pharmaceutica (Johnson & Johnson) Company Details
Table 139. Janssen Pharmaceutica (Johnson & Johnson) Business Overview
Table 140. Janssen Pharmaceutica (Johnson & Johnson) Product
Table 141. Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 142. Janssen Pharmaceutica (Johnson & Johnson) Recent Development
Table 143. LAURUS Labs Company Details
Table 144. LAURUS Labs Business Overview
Table 145. LAURUS Labs Product
Table 146. LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 147. LAURUS Labs Recent Development
Table 148. Medisist Pharma Company Details
Table 149. Medisist Pharma Business Overview
Table 150. Medisist Pharma Product
Table 151. Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 152. Medisist Pharma Recent Development
Table 153. Merck Company Details
Table 154. Merck Business Overview
Table 155. Merck Product
Table 156. Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 157. Merck Recent Development
Table 158. Mylan Company Details
Table 159. Mylan Business Overview
Table 160. Mylan Product
Table 161. Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 162. Mylan Recent Development
Table 163. Ranbaxy Pharmaceuticals Company Details
Table 164. Ranbaxy Pharmaceuticals Business Overview
Table 165. Ranbaxy Pharmaceuticals Product
Table 166. Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 167. Ranbaxy Pharmaceuticals Recent Development
Table 168. Shanghai Desano Pharmaceuticals Company Details
Table 169. Shanghai Desano Pharmaceuticals Business Overview
Table 170. Shanghai Desano Pharmaceuticals Product
Table 171. Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 172. Shanghai Desano Pharmaceuticals Recent Development
Table 173. ViiV Healthcare (GSK) Company Details
Table 174. ViiV Healthcare (GSK) Business Overview
Table 175. ViiV Healthcare (GSK) Product
Table 176. ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020) (Million US$)
Table 177. ViiV Healthcare (GSK) Recent Development
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type: 2020 VS 2026
Figure 2. Raltegravir Features
Figure 3. Elvitegravir Combination Drugs Features
Figure 4. Dolutegravir and Its Combination Drug Features
Figure 5. Bictegravir Combination Drug Features
Figure 6. Cabotegravir Features
Figure 7. Other Features
Figure 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application: 2020 VS 2026
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Drug Center Case Studies
Figure 12. Other Case Studies
Figure 13. HIV Integrase Strand Transfer Inhibitors (INSTI) Report Years Considered
Figure 14. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions: 2020 VS 2026
Figure 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players in 2019
Figure 19. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2019
Figure 20. The Top 10 and 5 Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2019
Figure 21. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Adcock Ingram Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Adcock Ingram Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 30. Affine Formulations Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Affine Formulations Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 32. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Aurobindo Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 34. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Biocon Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 36. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol-Myers Squibb Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 38. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Cipla Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 40. Emcure Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Emcure Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 42. Flamingo Pharmaceuticals Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Flamingo Pharmaceuticals Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 44. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Gilead Sciences Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 46. Hetero Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Hetero Drugs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 48. IPCA Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. IPCA Laboratories Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 50. Janssen Pharmaceutica (Johnson & Johnson) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Janssen Pharmaceutica (Johnson & Johnson) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 52. LAURUS Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. LAURUS Labs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 54. Medisist Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Medisist Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 56. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Merck Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 58. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Mylan Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 60. Ranbaxy Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Ranbaxy Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 62. Shanghai Desano Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Shanghai Desano Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 64. ViiV Healthcare (GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. ViiV Healthcare (GSK) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type: 2020 VS 2026
Figure 2. Raltegravir Features
Figure 3. Elvitegravir Combination Drugs Features
Figure 4. Dolutegravir and Its Combination Drug Features
Figure 5. Bictegravir Combination Drug Features
Figure 6. Cabotegravir Features
Figure 7. Other Features
Figure 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application: 2020 VS 2026
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Drug Center Case Studies
Figure 12. Other Case Studies
Figure 13. HIV Integrase Strand Transfer Inhibitors (INSTI) Report Years Considered
Figure 14. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions: 2020 VS 2026
Figure 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players in 2019
Figure 19. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2019
Figure 20. The Top 10 and 5 Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2019
Figure 21. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Adcock Ingram Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Adcock Ingram Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 30. Affine Formulations Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Affine Formulations Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 32. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Aurobindo Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 34. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Biocon Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 36. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol-Myers Squibb Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 38. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Cipla Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 40. Emcure Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Emcure Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 42. Flamingo Pharmaceuticals Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Flamingo Pharmaceuticals Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 44. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Gilead Sciences Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 46. Hetero Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Hetero Drugs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 48. IPCA Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. IPCA Laboratories Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 50. Janssen Pharmaceutica (Johnson & Johnson) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Janssen Pharmaceutica (Johnson & Johnson) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 52. LAURUS Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. LAURUS Labs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 54. Medisist Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Medisist Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 56. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Merck Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 58. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Mylan Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 60. Ranbaxy Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Ranbaxy Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 62. Shanghai Desano Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Shanghai Desano Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 64. ViiV Healthcare (GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. ViiV Healthcare (GSK) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
